SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-004674
Filing Date
2015-08-13
Accepted
2015-08-13 16:00:44
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_081315.htm 10-Q 665578
2 EXHIBIT 31.1 exh_311.htm EX-31.1 6340
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6260
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3622
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3695
  Complete submission text file 0001171843-15-004674.txt   5688964

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE amph-20150630.xml EX-101.INS 1057223
7 XBRL SCHEMA FILE amph-20150630.xsd EX-101.SCH 83080
8 XBRL CALCULATION FILE amph-20150630_cal.xml EX-101.CAL 51104
9 XBRL DEFINITION FILE amph-20150630_def.xml EX-101.DEF 366398
10 XBRL LABEL FILE amph-20150630_lab.xml EX-101.LAB 541765
11 XBRL PRESENTATION FILE amph-20150630_pre.xml EX-101.PRE 369889
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 151050613
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences